On October 12, 2021, Hollister Biosciences Inc. announced, in advance of its upcoming annual general and special meeting, a series of operational and strategic updates including a refreshed board of directors and a new Chief Executive Officer, Chief Financial Officer and Chief Commercial Officer.
Cassels represented Hollister.